# US 2021/0275581 A1 · Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275581 A1
- Document ID: US20210275581A1
- Status: Published application
- Kind: A1
- Application number: 17/249,489
- Filed: 2021-03-03
- Published: 2021-09-09
- Earliest claimed: 2020-03-06
- Assignees: Colgate-Palmolive Company
- Applicants: Colgate-Palmolive Company
- Inventors: Viktor Dubovoy; Long Pan
- Web page: https://patentgrep.com/patent/US20210275581A1

## CPC

- A61K 8/4926: {having six membered rings}
- A61K 33/30: Zinc; Compounds thereof
- A61K 8/27: Zinc; Compounds thereof
- A61P 31/04: Antibacterial agents
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61K 2800/58: Metal complex; Coordination compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Disclosed herein are oral care compositions comprising cetylpyridinium tetrachlorozincate for use in inhibiting growth of Streptococcus mutans in the oral cavity of a subject. In some embodiments, cetylpyridinium tetrachlorozincate is present in an amount of from 0.0001% to 1%, e.g., from 0.0001% to 0.009%, by weight of the composition.

## Claims

### Claim 1

A method of inhibiting growth of Streptococcus mutans in the oral cavity of a subject, comprising applying an oral care composition comprising cetylpyridinium tetrachlorozincate to the oral cavity.

### Claim 2 (depends on 1)

The method of claim 1, wherein cetylpyridinium tetrachlorozincate is present in an amount of from 0.0001% to 1% by weight of the composition.

### Claim 3 (depends on 2)

The method of claim 2, wherein cetylpyridinium tetrachlorozincate is present in an amount of from 0.0001% to 0.009% by weight of the composition.

### Claim 4 (depends on 1)

The method of claim 1, wherein the composition comprises a fluoride ion source.

### Claim 5 (depends on 1)

The method of claim 1, wherein the composition comprises an additional zinc ion source other than cetylpyridinium tetrachlorozincate.

### Claim 6 (depends on 1)

The method of claim 1, wherein the composition comprises a stannous ion source.

### Claim 7 (depends on 1)

The method of claim 1, wherein the composition comprises a basic amino acid, in free or salt from.

### Claim 8 (depends on 1)

The method of claim 1, wherein the composition comprises a surfactant.

### Claim 9 (depends on 1)

The method of claim 1, wherein the subject is in need of inhibiting growth of Streptococcus mutans in the oral cavity.

### Claim 10

An oral care composition comprising cetylpyridinium tetrachlorozincate, wherein cetylpyridinium tetrachlorozincate is present in an amount of from 0.0001% to 0.009% by weight of the composition.

### Claim 11 (depends on 10)

The composition of claim 10, wherein cetylpyridinium tetrachlorozincate is present in an amount of from 0.0006% to 0.006% by weight of the composition.

### Claim 12 (depends on 10)

The composition of claim 10, wherein the composition comprises a fluoride ion source.

### Claim 13 (depends on 10)

The composition of claim 10, wherein the composition comprises an additional zinc ion source other than cetylpyridinium tetrachlorozincate.

### Claim 14 (depends on 10)

The composition of claim 10, wherein the composition comprises a stannous ion source.

### Claim 15 (depends on 10)

The composition of claim 10, wherein the composition comprises a basic amino acid, in free or salt from.

### Claim 16 (depends on 10)

The composition of claim 10, wherein the composition comprises a surfactant.

### Claim 17 (depends on 10)

The composition of claim 10 for use in inhibiting growth of Streptococcus mutans in the oral cavity of a subject.

### Claim 18

(canceled)
